MD Biosciences/Aggrecanase Activity ELISA/96 wells/M046008

价格
面议
货号:M046008
浏览量:127
品牌:MD Biosciences
服务
全国联保
正品保证
正规发票
签订合同
商品描述
  • Overview
  • Data/Specifications
  • Literature/Support
  • How It Works
  • Related Products

Overview

Overview:

Aggrecanases ADAMTS1, ADAMTS4 and ADAMTS5 are members of the ADAMTS-family of proteases (ADAMTS = A disintegrin and metalloprotease with thrombospondin motif). They aresynthesized as multidomain proteins consisting of prodomains, protease, disintegrin, thrombospondin and cys-rich domains followed by spacer regions and additional thrombospondin motifs. The prodomains are cleaved-off intracellularly and the enzymes are processed further from their C-terminal ends after secretion.

Aggrecanases cleave specific peptide bonds in aggrecan, the main proteoglycan of articular cartilage. They hydrolyze also other lecticanes as versican and brevican. Convincing evidence indicates that aggrecanases are mainly responsible for excessive aggrecan degradation in osteoarthritic joints.

Data/Specifications

Data/Specifications:

Species: human

Sample Type: cell culture supernates

Sample Size: 100 uL

Standard Curve Range: 0.062 - 4 nM

Sensitivity: 0.025 nM

Assay Length:3.75 hours

Literature/Support

Literature/Support/Publications:

Product Insert:

Aggrecanase Activity Assay Insert (PDF)

Articles/FAQ:

ELISA Troubleshooting Guide

ELISA Data Reduction Guide

Measuring aggrecanase activity to identify potential therapeutics for osteoarthritis. (Blog Post)

How It Works

How It Works:

The Aggrecanase Activity Assay measures activity of aggrecanases. It is used to screen and characterize aggrecanase inhibitors. This assay consists of two modules, the Aggrecanase Module and the ELISA Module. A recombinant fragment of human aggrecan interglobular domain (aggrecan-IGD) is first digested with ag- grecanase. Proteolytic cleavage of the substrate releases an aggrecan peptide with the N-terminal sequence ARGSVIL (ARGSVIL-peptide). The ARGSVIL-peptide is then quantified with two monoclonal anti-peptide antibodies.

Aggrecanase module:Proteolysis of aggrecan-IGD by aggrecanase

Aggrecan-IGD is incubated with standard aggrecanase and samples of unknown aggrecanase activity. In addition to aggrecanase, different concentrations of aggrecanase inhibitors can be added. The reaction is then stopped by dilution with EDTA-containing buffer.

ELISA module: Aggrecan peptide ELISA

ARGSVIL-peptide standard, proteolytic digestions of aggrecan-IGD with standard aggrecanase and samples are incubated in microtiter wells precoated with anti-ARGSVIL-neoepitope antibody. ARGSVIL-peptide is bound to the coated antibody, while other components are removed by washing and aspiration. The bound ARGSVIL-peptide is detected with a second peroxidase-labeled antibody. Any excess of the conjugate is removed by washing and aspiration. The amounts of peroxidase bound to different wells are determined in reactions with peroxidase substrate TMB. The reactions are stopped by addition of sulfuric acid solution and absorbance is read at 450 nm in a microtiter plate spectrophotometer.

Related Products

MD Biosciences定制的基于细胞的检测测试服务MD Biosciences使用原代或永生化细胞系进行基于细胞的检测,用于筛选和作用机理研究。我们的科学团队与您一起确定最适合您需要的测定设计。我们的化验开发经验涉及广泛的研究目标,并且通过选择正确的细胞系统,刺激物,时间点和终点读数,针对每个试验研究针对赞助商的相关性进行了定制。 符合研究目标的 我们的菜单包括但不限于定制细胞培养,蛋白质表达和生物测定开发。尽管大多数研究使用患者来源的PBMC或已建立的细胞系,例如巨噬细胞U937或RAW264.7细胞,HUVEC内皮细胞,A549肺泡细胞或神经元细胞,但实际上任何类型的细胞都可以在研究中建立和使用。我们自豪地为GLP兼容实验室提供实验室服务,这些项目致力于FDA批准用于临床设置,从而允许通过临床前测定验证来进行定制测定开发,以用于临床药物开发和治疗应用。